Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Status:
Completed

Trial end date:
2002-10-01

Target enrollment:

Participant gender:

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Phase 2

Pfizer